Image-guided ThinPrep Papanicolaou tests and cotesting with high-risk human papillomavirus in women aged 30 years and older in a low-risk private practice population

Cancer Cytopathology

Volumn 117, Issue 5, 2009, Pages 326-332

  Ge, Yimin ^a,b   Smith, Debora ^a   Schwartz, Mary R ^a,c   Mody, Dina R ^a,b  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cervical cancer; Human papillomavirus; Low risk population; Papanicolaou tests; Screening; ThinPrep imaging system

Indexed keywords

VIRUS DNA;

ADULT; ALPHAPAPILLOMAVIRUS; ARTICLE; BIOPSY; DIAGNOSTIC IMAGING; EVALUATION; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; ISOLATION AND PURIFICATION; METHODOLOGY; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PRECANCER; PRIVATE PRACTICE; RISK; UTERINE CERVIX; VAGINA SMEAR;

ADULT; ALPHAPAPILLOMAVIRUS; BIOPSY; CERVIX UTERI; DIAGNOSTIC IMAGING; DNA, VIRAL; FEMALE; FOLLOW-UP STUDIES; HISTOCYTOLOGICAL PREPARATION TECHNIQUES; HUMANS; PAPILLOMAVIRUS INFECTIONS; PRECANCEROUS CONDITIONS; PRIVATE PRACTICE; RISK; VAGINAL SMEARS;

EID: 73349087195     PISSN: None     EISSN: 19346638     Source Type: Journal    
DOI: 10.1002/cncy.20038     Document Type: Article

References (32)

1. Smith JS, Lindsay L, Hoots B, et al. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer. 2007; 121: 621-632.
2. Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Am J Obstet Gynecol. 2001; 185: 308-317.
3. Renshaw AA, Young NA, Birdsong GG, et al. Comparison of performance of conventional and ThinPrep gynecologic preparations in the College of American Pathologists Gynecologic Cytology Program. Arch Pathol Lab Med. 2004; 128: 17-22.
4. Cheung AN, Szeto EF, Leung BS, Khoo US, Ng AW. Liquid-based cytology and conventional cervical smears: a comparison study in an Asian screening population. Cancer. 2003; 99: 331-335.
5. Abulafia O, Pezzullo JC, Sherer DM. Performance of Thin-Prep liquid-based cervical cytology in comparison with conventionally prepared Papanicolaou smears: a quantitative survey. Gynecol Oncol. 2003; 90: 137-144.
6. Lozano R. Comparison of computer-assisted and manual screening of cervical cytology. Gynecol Oncol. 2007; 104: 134-138.
7. Dziura B, Quinn S, Richard K. Performance of an imaging system vs. manual screening in the detection of squamous intraepithelial lesions of the uterine cervix. Acta Cytol. 2006; 50: 309-311.
8. Chivukula M, Saad RS, Elishaev E, White S, Mauser N, Dabbs DJ. Introduction of the Thin Prep Imaging System (TIS): experience in a high volume academic practice. Cytojournal. 2007; 4:6.
9. Saslow D, Runowicz CD, Solomon D, et al. American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer. J Low Genit Tract Dis. 2003; 7: 67-86.
10. American College of Obstetricians and Gynecologists. ACOG practice bulletin. Cervical cytology screening. Number 45, August 2003. Int J Gynaecol Obstet. 2003; 83: 237-247.
11. Wright TC Jr. Cervical cancer screening in the 21st century: is it time to retire the PAP smear? Clin Obstet Gynecol. 2007; 50: 313-323.
12. Runowicz CD, Garozzo S. Human papillomavirus testing for primary cervical cancer screening. Curr Oncol Rep. 2008; 10: 533-537.
13. Datta SD, Koutsky LA, Ratelle S, et al. Human papillomavirus infection and cervical cytology in women screened for cervical cancer in the United States, 2003-2005. Ann Intern Med. 2008; 148: 493-500.
14. Zhao C, Elishaev E, Yuan KH, Yu J, Austin RM. Very low human papillomavirus DNA prevalence in mature women with negative computer-imaged liquid-based Pap tests. Cancer. 2007; 111: 292-297.
15. Cibas ES, Hong X, Crum CP, Feldman S. Age-specific detection of high risk HPV DNA in cytologically normal, computer-imaged ThinPrep Pap samples. Gynecol Oncol. 2007; 104: 702-706.
16. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review. Ann Intern Med. 2000; 132: 810-819.
17. Cuzick J, Clavel C, Petry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer. 2006; 119: 1095-1101.
18. Carpenter AB, Davey DD. ThinPrep Pap Test: performance and biopsy follow-up in a university hospital. Cancer. 1999; 87: 105-112.
19. Davey E, Barratt A, Irwig L, et al. Effect of study design and quality on unsatisfactory rates, cytology classifications, and accuracy in liquid-based versus conventional cervical cytology: a systematic review. Lancet. 2006; 367: 122-132.
20. Ronco G, Cuzick J, Pierotti P, et al. Accuracy of liquid based versus conventional cytology: overall results of new technologies for cervical cancer screening: randomised controlled trial. BMJ. 2007; 335:28.
21. Belinson J, Qiao YL, Pretorius R, et al. Shanxi Province Cervical Cancer Screening Study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia. Gynecol Oncol. 2001; 83: 439-444.
22. Roberts JM, Thurloe JK, Bowditch RC, et al. A 3-armed trial of the ThinPrep Imaging System. Diagn Cytopathol. 2007; 35: 96-102.
23. Davey E, d'Assuncao J, Irwig L, et al. Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study. BMJ. 2007; 335:31.
24. Cuzick J, Szarewski A, Cubie H, et al. Management of women who test positive for high-risk types of human papillomavirus: the HART study. Lancet. 2003; 362: 1871-1876.
25. Bigras G, de Marval F. The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women. Br J Cancer. 2005; 93: 575-581.
26. Ronco G, Segnan N, Giorgi-Rossi P, et al. Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst. 2006; 98: 765-774.
27. Eltoum IA, Chhieng DC, Crowe DR, Roberson J, Jin G, Broker TR. Significance and possible causes of false-negative results of reflex human Papillomavirus infection testing. Cancer. 2007; 111: 154-159.
28. Lonky NM, Felix J, Tsadik GW, Lonky S. False-negative hybrid capture II results related to altered adhesion molecule distribution in women with atypical squamous cells pap smear results and tissue-based human papillomavirus-positive high-grade cervical intraepithelial neoplasia. J Low Genit Tract Dis. 2004; 8: 285-291.
29. Grce M, Davies P. Human papillomavirus testing for primary cervical cancer screening. Expert Rev Mol Diagn. 2008; 8: 599-605.
30. Sherman ME, Lorincz AT, Scott DR, et al. Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: a 10-year cohort analysis. J Natl Cancer Inst. 2003; 95: 46-52.
31. Clavel C, Masure M, Bory JP, et al. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br J Cancer. 2001; 84: 1616-1623.
32. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical screening tests. J Low Genit Tract Dis. 2007; 11: 201-222.